-
Pharmaceutical Intermediates |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS No.: 197632-75-0
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS:197632-75-0 |C32H32N2O6
-
Pharmaceutical Intermediates |Immunology |Peptide synteze |Fmoc-Trp-OH |CAS No.:35737-15-6 |C26H22N2O4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-Trp-OH |CAS:35737-15-6 |C26H22N2O4
-
Pharmaceutical Intermediates |Immunology |Peptide synteze |Fmoc-His(Trt)-OH |CAS No.:109425-51-6 |C40H33N3O4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-His(Trt)-OH |CAS: 109425-51-6 |C40H33N3O4
-
Pharmaceutical Intermediates |Immunology |Peptide synteze |Fmoc-Lys(Boc)-OH |CAS No.: 71989-26-9
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-Lys(Boc)-OH |CAS:71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc)-OH 163619-04-3
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Immunology |Peptide synteze |Natuerlike Amino Acid |Fmoc-D-Trp(Boc)-OH |CAS:163619-04-3 |C31H30N2O6
-
Pharmaceutical Intermediates |Respiratory sykten |Pranlukast Intermediates |3'-Acetylamino-2'-hydroxyacetofenon |CAS No.103205-33-0
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Respiratory sykten |Pranlukast Intermediates |3'-Acetylamino-2'-hydroxyacetofenon |CAS:103205-33-0 |C10H11NO3
-
Pharmaceutical Intermediates |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYSINE |CAS No.42288-26-6
Profesjonele manufacturing en oanbod biopharmaceutical |Pharmaceutical Intermediates Reagents |Grûnstoffen |Anticoagulant API |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYSINE |CAS: 42288-26-6 |C9H8N2O2
-
Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |3-Broom-L-fenylalanine |CAS No.82311-69-1
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates |Lifitegrast Intermediates |3-Broom-L-fenylalanine |CAS: 82311-69-1 |C9H10BrNO2
-
Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |Boc-3-bromo-L-fenylalanine |CAS No.82278-73-7
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates |Integrin antagonist |Lifitegrast Intermediates |Boc-3-bromo-L-fenylalanine |CAS: 82278-73-7 |C14H18BrNO4
-
Farmaseutyske grûnstoffen en intermediates |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS No.334618-23-4
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Aktive Pharmaceutical Ingredient Intermediates |Diabetes |(R)-3-Aminopiperidine dihydrochloride |CAS: 334618-23-4 |C5H14Cl2N2
-
Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |Diabetes |CAS: 188111-79-7
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Pharmaceutical Intermediates |(R)-1-Boc-3-Aminopiperidine |CAS:188111-79-7 |C10H20N2O2
-
Raw Materials |Pharmaceutical Intermediates |Cardiovascular |Sykten |(S)-(-)-indoline-2-carboxylic acid |CAS No.79815-20-6
Profesjonele manufacturing en oanbod biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |Hege bloeddruk |(S)-(-)-indoline-2-carboxylic acid |CAS: 79815-20-6 |C9H9NO2